Article
Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical…
OncoTargets and Therapy · 2016 · Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD
Key facts
| Title | Decreased expression of SLC39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer |
|---|---|
| First author | Xu XM, Wang CG, Zhu YD, Chen WH, Shao SL, Jiang FN, Liao QD |
| Journal | OncoTargets and Therapy |
| Published | Jul 11, 2016 |
| DOI | 10.2147/OTT.S103640 |
| Devices mentioned | K870938 |
| Product codes mentioned | KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1